ARCHIVES

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

AACI Asks Funding Of Cancer Control Directors From Control Budget

February 11, 1983

Obey Attacks NCI In Campaign Speech

October 29, 1976

Hydridoma Cell Lines Available

March 5, 1982

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

November 22, 1991

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012